Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026)
Canton Strategic Holdings (CNTN) posted Assets Average of $551.9 million for Q1 2026, up 109.51% on a QoQ basis from $263.4 million in Q4 2025, and up 20405.63% year-over-year from N/an in Q1 2025.
Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026) Analysis & Trends
Canton Strategic Holdings' Assets Average history runs 5 years deep, the most recent figure standing at $551.9 million for Q1 2026.
- Quarterly Assets Average rose 20405.63% year-over-year to $551.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $551.9 million (up 20405.63% YoY) and the FY2025 annual result came in at $261.4 million, up 3464.68% from the prior year.
- Assets Average was $551.9 million for Q1 2026 at Canton Strategic Holdings, up from $263.4 million in the prior quarter.
- Across five years, Assets Average topped out at $551.9 million in Q1 2026 and bottomed at $2.1 million in Q2 2025.
- A 5-year average of $53.5 million and a median of $6.8 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2025 — Assets Average tumbled 75.55% — and 2026, when it surged 20405.63%.
- Canton Strategic Holdings' Assets Average stood at $7.4 million in 2022, then retreated by 4.04% to $7.1 million in 2023, then tumbled by 36.42% to $4.5 million in 2024, then surged by 5771.54% to $263.4 million in 2025, then jumped by 109.51% to $551.9 million in 2026.
- Business Quant data shows CNTN's Assets Average at $551.9 million in Q1 2026, $263.4 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 551.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551.90 Mn |
| Dec 31, 2025 | 263.42 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 8.57 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 3.88 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 11.17 Mn |
| Mar 31, 2022 | 6.36 Mn |